Bristol-Myers (BMY), Pfizer (PFE) Get Positive CHMP Opinion for ELIQUIS to Prevent Stroke in NVAF Patients
Go back to Bristol-Myers (BMY), Pfizer (PFE) Get Positive CHMP Opinion for ELIQUIS to Prevent Stroke in NVAF Patients| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 67.28 +1.23 (1.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.05 | 52 Week High | $77.12 | |||
| Open | $66.80 | 52 Week Low | $49.03 | |||
| Day High | $68.64 | P/E | 43.69 | |||
| Day Low | $66.61 | EPS | $1.54 | |||
| Volume | 6,945,230 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.15 +0.90 (3.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.25 | 52 Week High | $37.39 | |||
| Open | $27.60 | 52 Week Low | $28.25 | |||
| Day High | $28.44 | P/E | 17.06 | |||
| Day Low | $27.58 | EPS | $1.65 | |||
| Volume | 38,736,123 | |||||
